The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...

Former U.S. Patent and Trademark Office (USPTO) Director Kathi Vidal, now with Winston & Strawn, filed an amicus brief on Wednesday in an appeal to the U.S. Court of Appeals for the Federal ...

Inc. reported its Q1 FY2025 earnings, revealing a net loss per share of $0.06, which was better than the projected loss of $0.08. The company's revenue reached $3.2 million, surpassing the forecast of ...

Dihydroergotamine mesylate – generic, DHE 45® 1 mg/ml ampules 1 mg im. or sc.; can be repeated at 1 h intervals (max 3 mg/24 h, 6 mg/week) Migranal® nasal spray 4 mg/ml nasal spray One spray ...

Generic Eng Standalone December 2023 Net Sales at Rs 58.97 crore, down 5.09% Y-o-Y Mar 01 2024 01:54 PM Generic Eng Standalone September 2023 Net Sales at Rs 37.20 crore, down 30.48% Y-o-Y Dec 04 ...